Absci (ABSI) Stock Price
$2.73 3%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Absci, AI stock picks, stock alerts and much more.
ABSI AI Stock Analysis
AI stock analysis for ABSI is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Absci (ABSI) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Absci (ABSI) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Absci (ABSI), currently trading at $2.73, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ABSI
-
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States.
-
Symbol
ABSI
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
348.2M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$24.9 0.2% |
7 |
 |
Inovio Pharmaceuticals INO |
$2.1 5% |
2 |
 |
Moderna MRNA |
$27.05 1.8% |
3 |
 |
Anavex Life Sciences AVXL |
$7.56 0.4% |
6 |
 |
BridgeBio Pharma BBIO |
$35.46 3.5% |
7 |
News
ABSI Alternative Data
Web Traffic
Absci receives an estimated 10986 monthly visitors to absci.com.
-
Web Traffic
10986
-
Change from Previous Month
43.1%
-
3 Month Change
41.7%
-
YoY Change
41.7%
Reddit Mentions
Absci has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Facebook Engagement
Absci has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Youtube Subscribers
Absci has 496 subscribers on its main Youtube channel, up by 2.1% over the last month.
-
Youtube Subscribers
496
-
Daily Change
0%
-
1 Month Change
2.1%
-
3 Month Change
6.2%
-
YoY Change
6.2%
LinkedIn Followers
15,257 are following Absci on LinkedIn, up by 2.8% over the last month.
-
LinkedIn Followers
15257
-
Daily Change
0%
-
1 Month Change
2.8%
-
3 Month Change
6.8%
Job Postings
Absci currenly has an estimated 3 open job postings.
-
Job Postings
3
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
50%
-
YoY Change
50%
LinkedIn Employees
According to LinkedIn, Absci has 193 employees, up by 1% over the last month.
-
LinkedIn Employees
193
-
Daily Change
0.5%
-
1 Month Change
1%
-
3 Month Change
3.2%
-
YoY Change
3.2%
Twitter Followers
Absci has 2,587 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.
-
Twitter Followers
2587
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
2%
-
YoY Change
2%
Business Outlook
According to employee reviews, the business outlook among employees at Absci is 44 out of 100 (neutral), down by -6.4% over the last month.
-
Business Outlook
44
-
Change from Previous Month
6.4%
-
3 Month Change
57.1%
-
YoY Change
57.1%
News Mentions
Absci was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
ABSI Financials
ABSI Key Metrics
-
Total Revenue
$665K
-
Net Income
-$29M
-
Earnings per Share
-$0.25
-
Free cash flow
-$17M
-
EBITDA
-$25.6M
-
EBITDA Ratio
-38.5248
-
Total Assets
$213.6M
ABSI 2-year Revenue & Income
ABSI 2-year Free Cash Flow
ABSI Technicals
ABSI SMA
ABSI RSI
FAQ
What's the current price of Absci (ABSI) Stock?
The price of an Absci (ABSI) share is $2.73.
What's the market cap of Absci?
The current market cap of Absci is 348.2M.
Should I buy or sell ABSI?
Absci shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Absci is better viewed as a hold or accumulate position while waiting for further developments.
Is Absci a good investment?
The current analysis of Absci's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Absci's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Absci (ABSI) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Absci stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Absci (ABSI) that investors often compare it to?
Absci (ABSI) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Absci's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Absci's stock price to be around $2.56 in 2026. Starting from the current price of $2.73, this represents a 6.1% change in price, indicating a bearish outlook for the stock.
How to buy Absci (ABSI) Stock?
Absci stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Absci shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.